DENTSPLY SIRONA (XRAY) Financials

$10.07 -0.34 (-3.27%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$10.11 +0.04 (+0.40%)

As of 05/15/2026 07:49 PM Eastern

Annual Income Statements for DENTSPLY SIRONA

This table shows DENTSPLY SIRONA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	251	430	-1,550	-1,011	256	-73	411	-950	-132	-910	-598
Consolidated Net Income / (Loss)	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910	-598
Net Income / (Loss) Continuing Operations	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910	-598
Total Pre-Tax Income	330	441	-1,604	-958	338	-50	545	-1,055	-175	-936	-486
Total Operating Income	375	455	-1,562	-958	353	-3.00	608	-937	-85	-879	-422
Total Gross Profit	1,517	2,001	2,189	2,068	2,164	1,656	2,347	2,127	2,086	1,958	1,840
Total Revenue	2,674	3,745	3,993	3,986	4,022	3,339	4,231	3,922	3,965	3,793	3,680
Operating Revenue	2,674	3,745	3,993	3,986	4,022	3,339	4,231	3,922	3,965	3,793	3,680
Total Cost of Revenue	1,157	1,744	1,805	1,918	1,858	1,683	1,884	1,795	1,879	1,835	1,840
Operating Cost of Revenue	1,157	1,744	1,805	1,918	1,858	1,683	1,884	1,795	1,879	1,835	1,840
Total Operating Expenses	1,142	1,546	3,751	3,026	1,811	1,659	1,739	3,064	2,171	2,837	2,262
Selling, General & Admin Expense	1,077	1,523	1,675	1,719	1,587	1,302	1,551	1,589	1,613	1,605	1,438
Research & Development Expense	-	-	-	-	143	123	171	174	184	165	150
Impairment Charge	0.00	0.00	1,651	1,086	0.00	234	0.00	1,287	307	1,014	650
Restructuring Charge	65	23	425	221	81	-	17	14	67	53	24
Total Other Income / (Expense), net	-46	-14	-41	0.00	-15	-47	-63	-118	-90	-57	-64
Interest Expense	56	36	38	37	-	-	61	65	81	69	88
Other Income / (Expense), net	8.20	20	-5.30	35	12	-1.00	-2.00	-53	-9.00	12	24
Income Tax Expense	77	9.50	-53	53	82	23	134	-105	-43	-26	112
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.10	1.50	-0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basic Earnings per Share	$1.79	$1.97	($6.76)	($4.51)	$1.15	($0.33)	$1.88	($4.41)	($0.62)	($4.48)	($3.00)
Weighted Average Basic Shares Outstanding	140M	218M	229.40M	224.30M	223.10M	219.20M	218.40M	215.50M	212M	203.20M	199.40M
Diluted Earnings per Share	$1.76	$1.94	($6.76)	($4.51)	$1.14	($0.33)	$1.87	($4.41)	($0.62)	($4.48)	($3.00)
Weighted Average Diluted Shares Outstanding	142.70M	221.60M	229.40M	224.30M	224.40M	219.20M	220.20M	215.50M	212M	203.20M	199.40M
Weighted Average Basic & Diluted Shares Outstanding	140.30M	218.20M	229.30M	224.20M	221.44M	219.05M	217.55M	215.36M	207.36M	198.99M	199.75M
Cash Dividends to Common per Share	$0.29	$0.31	$0.35	$0.35	$0.38	$0.40	$0.43	$0.50	$0.56	$0.64	$0.64

This table shows DENTSPLY SIRONA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-266	67	18	-4.00	-494	-430	20	-45	-427	-146	-10
Consolidated Net Income / (Loss)	-266	72	17	-4.00	-495	-428	19	-44	-428	-145	-10
Net Income / (Loss) Continuing Operations	-266	72	17	-4.00	-495	-428	19	-44	-428	-145	-10
Total Pre-Tax Income	-250	57	31	34	-478	-523	44	-153	-230	-147	-42
Total Operating Income	-236	73	42	50	-462	-509	63	-128	-218	-139	-35
Total Gross Profit	495	522	506	511	495	446	466	490	441	443	427
Total Revenue	947	1,012	953	984	951	905	879	936	904	961	880
Operating Revenue	947	1,012	953	984	951	905	879	936	904	961	880
Total Cost of Revenue	452	490	447	473	456	459	413	446	463	518	453
Operating Cost of Revenue	452	490	447	473	456	459	413	446	463	518	453
Total Operating Expenses	731	449	464	461	957	955	403	618	659	582	462
Selling, General & Admin Expense	372	409	415	399	390	401	358	342	355	383	351
Research & Development Expense	46	43	42	41	40	42	36	37	37	40	44
Restructuring Charge	6.00	-3.00	1.00	21	23	8.00	9.00	4.00	5.00	6.00	67
Total Other Income / (Expense), net	-14	-16	-11	-16	-16	-14	-19	-25	-12	-8.00	-7.00
Interest Expense	19	20	18	17	18	16	19	24	23	22	24
Other Income / (Expense), net	5.00	4.00	7.00	1.00	2.00	2.00	0.00	-1.00	11	14	17
Income Tax Expense	16	-15	14	38	17	-95	25	-109	198	-2.00	-32
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	5.00	-1.00	0.00	-1.00	2.00	-1.00	1.00	-1.00	1.00	0.00
Basic Earnings per Share	($1.25)	$0.31	$0.09	($0.02)	($2.46)	($2.09)	$0.10	($0.22)	($2.14)	($0.74)	($0.05)
Weighted Average Basic Shares Outstanding	211.80M	212M	207.40M	205.60M	201M	203.20M	199.10M	199.30M	199.50M	199.40M	199.90M
Diluted Earnings per Share	($1.25)	$0.32	$0.09	($0.02)	($2.46)	($2.09)	$0.10	($0.22)	($2.14)	($0.74)	($0.05)
Weighted Average Diluted Shares Outstanding	211.80M	212M	208.50M	205.60M	201M	203.20M	199.80M	199.30M	199.50M	199.40M	199.90M
Weighted Average Basic & Diluted Shares Outstanding	211.86M	207.36M	207.63M	202.71M	198.78M	198.99M	199.29M	199.48M	199.55M	199.75M	200.33M

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	133	99	-63	-3.00	95	33	-99	26	-31	-62	54
Net Cash From Operating Activities	497	563	602	500	639	649	657	517	377	461	235
Net Cash From Continuing Operating Activities	497	563	602	500	639	649	657	517	377	461	235
Net Income / (Loss) Continuing Operations	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910	-598
Consolidated Net Income / (Loss)	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910	-598
Depreciation Expense	79	117	127	133	133	142	124	119	132	133	141
Amortization Expense	55	160	192	201	190	192	222	209	211	216	211
Non-Cash Adjustments To Reconcile Net Income	47	9.10	2,122	1,273	116	250	51	1,445	352	1,063	673
Changes in Operating Assets and Liabilities, net	66	-153	-289	-96	-56	138	-151	-306	-186	-41	-192
Net Cash From Investing Activities	-55	60	-286	-253	-69	-1,106	-358	-138	-89	-197	-132
Net Cash From Continuing Investing Activities	-55	60	-286	-253	-69	-1,106	-358	-138	-89	-197	-132
Purchase of Property, Plant & Equipment	-72	-125	-144	-183	-123	-87	-142	-149	-149	-180	-131
Purchase of Investments	-6.30	-24	-2.50	-6.00	-	-	-	0.00	0.00	-12	-14
Divestitures	0.00	528	0.00	0.00	11	1.00	28	0.00	13	0.00	0.00
Sale and/or Maturity of Investments	78	20	6.50	62	40	58	2.00	13	39	1.00	10
Other Investing Activities, net	-1.40	-1.70	-0.90	-	6.00	0.00	2.00	-2.00	8.00	-6.00	3.00
Net Cash From Financing Activities	-303	-526	-401	-250	-472	476	-379	-329	-307	-302	-80
Net Cash From Continuing Financing Activities	-303	-526	-401	-250	-472	476	-379	-329	-307	-302	-80
Repayment of Debt	-270	-922	-17	-9.00	-360	-727	-154	-81	109	73	-940
Repurchase of Common Equity	-113	-814	-401	-250	-260	-140	-200	-150	-300	-250	0.00
Payment of Dividends	-40	-65	-78	-79	-81	-88	-92	-104	-116	-126	-128
Issuance of Debt	153	1,221	13	60	120	1,450	16	6.00	0.00	1.00	988
Other Net Changes in Cash	-	-	22	-	-	14	-	-	-	-	31
Cash Interest Paid	55	37	37	35	30	45	64	70	97	91	66
Cash Income Taxes Paid	71	112	123	105	112	82	148	122	177	74	71

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	14	25	-43	-12	17	-24	126	-39	4.00	-37	-136
Net Cash From Operating Activities	134	160	25	208	141	87	7.00	48	79	101	40
Net Cash From Continuing Operating Activities	134	160	25	208	141	87	7.00	48	79	101	40
Net Income / (Loss) Continuing Operations	-266	72	17	-4.00	-495	-428	19	-44	-428	-145	-10
Consolidated Net Income / (Loss)	-266	72	17	-4.00	-495	-428	19	-44	-428	-145	-10
Depreciation Expense	35	33	32	32	35	34	34	34	36	37	38
Amortization Expense	53	52	54	54	54	54	45	54	56	56	41
Non-Cash Adjustments To Reconcile Net Income	302	-17	36	31	514	482	19	254	262	138	-13
Changes in Operating Assets and Liabilities, net	10	20	-114	95	33	-55	-110	-250	153	15	-16
Net Cash From Investing Activities	-2.00	-20	-43	-50	-47	-57	-17	-34	-36	-45	-53
Net Cash From Continuing Investing Activities	-2.00	-20	-43	-50	-47	-57	-17	-34	-36	-45	-53
Purchase of Property, Plant & Equipment	-37	-40	-34	-52	-43	-51	-19	-32	-39	-41	-52
Purchase of Investments	-	-	-9.00	-	-3.00	-	0.00	-2.00	-7.00	-5.00	-7.00
Other Investing Activities, net	-	7.00	-	-	-	-7.00	2.00	-	-	1.00	6.00
Net Cash From Financing Activities	-109	-128	-14	-171	-79	-38	123	-68	-36	-99	-119
Net Cash From Continuing Financing Activities	-109	-128	-14	-171	-79	-38	123	-68	-36	-99	-119
Repayment of Debt	-7.00	-4.00	15	-8.00	-2.00	-86	-280	-586	-5.00	-69	-87
Payment of Dividends	-29	-30	-29	-33	-33	-31	-32	-32	-32	-32	-32
Issuance of Debt	-73	56	0.00	20	56	79	435	550	1.00	2.00	0.00
Other Net Changes in Cash	-	-	-11	-	-	-	-	-	-	6.00	-4.00
Cash Interest Paid	-	-	15	-	-	-	13	-	-	-	44

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	4,403	11,556	10,375	8,687	8,603	9,350	9,239	7,643	7,370	5,753	5,429
Total Current Assets	1,197	1,744	2,003	1,888	2,000	1,798	1,852	1,893	1,973	1,746	2,023
Cash & Equivalents	285	384	321	310	405	438	339	365	334	272	326
Note & Lease Receivable	400	636	746	702	782	667	750	632	695	556	688
Inventories, net	340	517	623	599	562	476	515	627	624	564	642
Prepaid Expenses	172	207	313	278	251	217	248	269	320	354	367
Plant, Property, & Equipment, net	559	800	876	871	802	791	773	761	800	766	861
Total Noncurrent Assets	2,647	9,013	7,496	5,928	5,801	6,761	6,614	4,989	4,597	3,241	2,545
Goodwill	1,988	5,952	4,539	3,431	3,397	3,986	3,976	2,688	2,438	1,597	1,148
Intangible Assets	601	2,958	2,801	2,420	2,176	2,504	2,319	1,903	1,705	1,207	974
Other Noncurrent Operating Assets	59	103	156	77	228	271	319	398	454	437	423
Total Liabilities & Shareholders' Equity	4,403	11,556	10,375	8,687	8,603	9,350	9,239	7,643	7,370	5,753	5,429
Total Liabilities	2,064	3,430	3,747	3,554	3,508	4,415	4,242	3,831	4,076	3,810	4,089
Total Current Liabilities	476	768	955	1,013	995	1,372	1,261	1,170	1,425	1,589	1,343
Short-Term Debt	12	21	30	92	2.00	299	182	118	322	549	313
Accounts Payable	134	223	284	284	308	302	262	279	305	241	300
Accrued Expenses	310	463	586	579	629	712	760	727	749	754	700
Current Deferred & Payable Income Tax Liabilities	20	61	54	58	56	59	57	46	49	45	30
Total Noncurrent Liabilities	1,588	2,662	2,792	2,541	2,513	3,043	2,981	2,661	2,651	2,221	2,746
Long-Term Debt	1,141	1,511	1,612	1,565	1,433	1,978	1,913	1,826	1,796	1,586	2,015
Noncurrent Deferred & Payable Income Tax Liabilities	160	752	718	553	480	381	391	287	228	129	94
Other Noncurrent Operating Liabilities	286	400	463	423	600	684	677	548	627	506	637
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,339	8,126	6,628	5,133	5,095	4,935	4,997	3,812	3,294	1,943	1,340
Total Preferred & Common Equity	2,338	8,114	6,616	5,121	5,093	4,932	4,996	3,811	3,293	1,942	1,339
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,338	8,114	6,616	5,121	5,093	4,932	4,996	3,811	3,293	1,942	1,339
Common Stock	239	6,519	6,547	6,525	6,590	6,607	6,609	6,632	6,646	6,643	6,647
Retained Earnings	3,591	3,948	2,316	1,226	1,404	1,198	1,514	456	205	-835	-1,564
Treasury Stock	-898	-1,647	-1,955	-2,151	-2,301	-2,409	-2,535	-2,649	-2,922	-3,136	-3,105
Accumulated Other Comprehensive Income / (Loss)	-594	-706	-291	-479	-600	-464	-592	-628	-636	-730	-639
Noncontrolling Interest	1.40	12	12	12	2.00	3.00	1.00	1.00	1.00	1.00	1.00

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	7,522	7,673	7,650	7,201	7,123	6,897	6,626	6,050	6,069	5,653	5,229
Total Current Assets	1,939	1,943	1,920	1,913	1,902	1,758	1,921	1,978	1,966	2,072	1,845
Cash & Equivalents	418	318	295	309	291	279	296	398	359	363	190
Note & Lease Receivable	645	652	670	649	656	591	671	604	646	654	622
Inventories, net	592	659	657	651	613	608	619	612	675	686	659
Prepaid Expenses	284	314	298	304	342	280	335	364	286	369	374
Plant, Property, & Equipment, net	714	770	772	753	782	789	817	791	840	841	858
Total Noncurrent Assets	4,869	4,960	4,958	4,535	4,439	4,350	3,888	3,281	3,263	2,740	2,526
Goodwill	2,584	2,701	2,703	2,374	2,400	2,389	1,937	1,632	1,528	1,270	1,142
Intangible Assets	1,875	1,862	1,808	1,711	1,618	1,559	1,538	1,212	1,133	1,065	924
Other Noncurrent Operating Assets	410	397	447	450	421	402	413	437	602	405	460
Total Liabilities & Shareholders' Equity	7,522	7,673	7,650	7,201	7,123	6,897	6,626	6,050	6,069	5,653	5,229
Total Liabilities	3,908	4,035	3,948	3,830	3,865	3,833	4,136	4,040	4,108	4,175	3,910
Total Current Liabilities	1,296	1,374	1,271	1,218	1,330	1,323	1,542	1,793	1,166	1,405	1,207
Short-Term Debt	246	316	261	187	343	362	422	742	184	378	230
Accounts Payable	271	267	265	262	279	287	297	276	268	268	259
Accrued Expenses	711	748	728	732	681	650	798	738	672	712	688
Current Deferred & Payable Income Tax Liabilities	68	43	17	37	27	24	25	37	42	47	30
Total Noncurrent Liabilities	2,612	2,661	2,677	2,612	2,535	2,510	2,594	2,247	2,942	2,770	2,703
Long-Term Debt	1,737	1,842	1,841	1,803	1,747	1,737	1,795	1,593	2,218	2,017	2,006
Noncurrent Deferred & Payable Income Tax Liabilities	246	271	261	249	214	194	193	134	109	95	84
Other Noncurrent Operating Liabilities	629	548	575	560	574	579	606	520	615	658	613
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,614	3,638	3,702	3,371	3,258	3,064	2,490	2,010	1,961	1,478	1,319
Total Preferred & Common Equity	3,613	3,641	3,706	3,375	3,258	3,064	2,491	2,010	1,960	1,478	1,318
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,613	3,641	3,706	3,375	3,258	3,064	2,491	2,010	1,960	1,478	1,318
Common Stock	6,622	6,607	6,651	6,648	6,642	6,634	6,642	6,634	6,641	6,641	6,619
Retained Earnings	498	407	463	167	190	152	-374	-848	-925	-1,385	-1,574
Treasury Stock	-2,663	-2,759	-2,788	-2,783	-2,908	-3,045	-3,139	-3,117	-3,115	-3,106	-3,072
Accumulated Other Comprehensive Income / (Loss)	-844	-614	-620	-657	-666	-677	-638	-659	-641	-672	-655
Noncontrolling Interest	1.00	-3.00	-4.00	-4.00	0.00	0.00	-1.00	0.00	1.00	0.00	1.00

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.50%	40.05%	6.62%	-0.19%	0.90%	-16.98%	26.71%	-7.30%	1.10%	-4.34%	-2.98%
EBITDA Growth	-10.67%	45.09%	-266.26%	52.83%	216.81%	-52.03%	188.48%	-169.54%	137.61%	-308.03%	91.12%
EBIT Growth	-13.98%	23.84%	-430.16%	41.12%	139.55%	-101.10%	15,250.00%	-263.37%	90.51%	-822.34%	54.09%
NOPAT Growth	-19.27%	54.71%	-345.81%	38.68%	139.87%	-100.79%	21,933.81%	-243.05%	90.93%	-934.12%	51.99%
Net Income Growth	-22.24%	71.80%	-459.36%	34.79%	125.32%	-128.52%	663.01%	-331.14%	86.11%	-589.39%	34.29%
EPS Growth	-21.43%	10.23%	-448.45%	33.28%	125.28%	-128.95%	666.67%	-335.83%	85.94%	-622.58%	33.04%
Operating Cash Flow Growth	-11.24%	13.27%	6.83%	-16.93%	27.80%	1.56%	1.23%	-21.31%	-27.08%	22.28%	-49.02%
Free Cash Flow Firm Growth	-43.27%	-1,197.56%	104.12%	244.44%	-21.89%	-204.50%	173.65%	47.25%	-64.10%	159.05%	-74.33%
Invested Capital Growth	-6.54%	189.11%	-14.29%	-18.47%	-5.49%	10.60%	-0.31%	-20.17%	-5.81%	-25.05%	-12.19%
Revenue Q/Q Growth	-1.76%	9.51%	2.42%	-0.79%	1.13%	-0.40%	0.28%	-2.97%	0.74%	-2.74%	1.55%
EBITDA Q/Q Growth	-0.32%	12.34%	-204.09%	57.19%	7.35%	10.55%	1.60%	-28.79%	25.76%	-922.22%	89.38%
EBIT Q/Q Growth	-1.92%	10.03%	-116.94%	46.13%	15.73%	83.94%	2.89%	-16.75%	32.37%	-206.36%	48.97%
NOPAT Q/Q Growth	-5.32%	7.15%	-116.48%	45.14%	53.99%	89.40%	1.58%	-12.89%	8.60%	-195.96%	46.72%
Net Income Q/Q Growth	-9.40%	12.90%	-95.70%	39.19%	58.02%	21.17%	0.98%	-16.42%	39.73%	-121.95%	32.12%
EPS Q/Q Growth	-9.74%	0.00%	-92.05%	38.47%	62.86%	21.43%	1.63%	-16.05%	38.00%	-116.43%	31.03%
Operating Cash Flow Q/Q Growth	-11.76%	20.54%	1.09%	-5.03%	19.24%	-6.01%	-6.01%	-13.40%	5.01%	-13.67%	6.33%
Free Cash Flow Firm Q/Q Growth	-34.58%	6.27%	-36.64%	-8.17%	8.20%	-227.07%	169.47%	-35.69%	309.53%	51.63%	-51.36%
Invested Capital Q/Q Growth	0.24%	-3.52%	-9.07%	-2.56%	-1.98%	18.50%	-1.53%	4.09%	0.51%	-13.72%	-4.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.73%	53.42%	54.80%	51.88%	53.80%	49.60%	55.47%	54.23%	52.61%	51.62%	50.00%
EBITDA Margin	19.35%	20.05%	-31.27%	-14.78%	17.11%	9.88%	22.50%	-16.88%	6.28%	-13.66%	-1.25%
Operating Margin	14.03%	12.14%	-39.12%	-24.03%	8.78%	-0.09%	14.37%	-23.89%	-2.14%	-23.17%	-11.47%
EBIT Margin	14.34%	12.68%	-39.25%	-23.16%	9.08%	-0.12%	14.32%	-25.24%	-2.37%	-22.86%	-10.82%
Profit (Net Income) Margin	9.39%	11.52%	-38.82%	-25.36%	6.37%	-2.19%	9.71%	-24.22%	-3.33%	-23.99%	-16.25%
Tax Burden Percent	76.16%	97.85%	96.68%	105.53%	75.74%	146.00%	75.41%	90.05%	75.43%	97.22%	123.05%
Interest Burden Percent	85.99%	92.86%	102.29%	103.79%	92.60%	1,250.00%	89.93%	106.57%	186.17%	107.96%	122.11%
Effective Tax Rate	23.35%	2.15%	0.00%	0.00%	24.26%	0.00%	24.59%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	8.66%	7.13%	-12.70%	-9.29%	4.24%	-0.03%	6.78%	-10.80%	-1.14%	-13.85%	-8.27%
ROIC Less NNEP Spread (ROIC-NNEP)	4.97%	5.79%	-49.69%	-34.80%	3.29%	-4.98%	4.14%	-28.44%	-5.45%	-30.01%	-23.92%
Return on Net Nonoperating Assets (RNNOA)	2.11%	1.12%	-8.32%	-7.90%	0.76%	-1.42%	1.50%	-10.77%	-2.58%	-20.90%	-28.16%
Return on Equity (ROE)	10.77%	8.24%	-21.02%	-17.19%	5.01%	-1.46%	8.28%	-21.57%	-3.72%	-34.75%	-36.43%
Cash Return on Invested Capital (CROIC)	15.43%	-90.07%	2.69%	11.06%	9.89%	-10.10%	7.09%	11.63%	4.84%	14.78%	4.72%
Operating Return on Assets (OROA)	8.47%	5.95%	-14.30%	-9.68%	4.22%	-0.04%	6.52%	-11.73%	-1.25%	-13.21%	-7.12%
Return on Assets (ROA)	5.55%	5.41%	-14.14%	-10.61%	2.96%	-0.81%	4.42%	-11.25%	-1.76%	-13.87%	-10.70%
Return on Common Equity (ROCE)	10.77%	8.23%	-20.98%	-17.16%	5.00%	-1.45%	8.27%	-21.56%	-3.71%	-34.74%	-36.41%
Return on Equity Simple (ROE_SIMPLE)	10.74%	5.32%	-23.43%	-19.74%	5.03%	-1.48%	8.23%	-24.93%	-4.01%	-46.86%	0.00%
Net Operating Profit after Tax (NOPAT)	288	445	-1,094	-671	267	-2.10	459	-656	-60	-615	-295
NOPAT Margin	10.75%	11.88%	-27.39%	-16.82%	6.65%	-0.06%	10.84%	-16.72%	-1.50%	-16.22%	-8.03%
Net Nonoperating Expense Percent (NNEP)	3.69%	1.34%	36.99%	25.51%	0.96%	4.94%	2.64%	17.64%	4.31%	16.16%	15.66%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-11.40%	-1.10%	-15.09%	-8.05%
Cost of Revenue to Revenue	43.27%	46.58%	45.20%	48.12%	46.20%	50.40%	44.53%	45.77%	47.39%	48.38%	50.00%
SG&A Expenses to Revenue	40.28%	40.66%	41.94%	43.13%	39.46%	38.99%	36.66%	40.52%	40.68%	42.31%	39.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	3.56%	3.68%	4.04%	4.44%	4.64%	4.35%	4.08%
Operating Expenses to Revenue	42.70%	41.28%	93.93%	75.92%	45.03%	49.69%	41.10%	78.12%	54.75%	74.80%	61.47%
Earnings before Interest and Taxes (EBIT)	383	475	-1,568	-923	365	-4.00	606	-990	-94	-867	-398
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	518	751	-1,249	-589	688	330	952	-662	249	-518	-46
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.35	1.52	2.12	1.52	2.33	2.21	2.34	1.72	2.23	1.94	1.70
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.93	3.29	3.52	1.95	2.95	3.27	2.77	1.67	1.85	0.99	0.62
Price to Earnings (P/E)	31.17	28.67	0.00	0.00	46.42	0.00	28.49	0.00	0.00	0.00	0.00
Dividend Yield	0.52%	0.58%	0.57%	1.00%	0.70%	0.80%	0.80%	1.64%	1.61%	3.37%	5.60%
Earnings Yield	3.21%	3.49%	0.00%	0.00%	2.15%	0.00%	3.51%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.71	1.45	1.94	1.41	2.11	1.88	1.99	1.51	1.80	1.48	1.28
Enterprise Value to Revenue (EV/Rev)	3.25	3.60	3.85	2.29	3.21	3.82	3.18	2.08	2.30	1.49	1.16
Enterprise Value to EBITDA (EV/EBITDA)	16.81	17.95	0.00	0.00	18.77	38.63	14.14	0.00	36.68	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	22.69	28.40	0.00	0.00	35.38	0.00	22.22	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	30.25	30.31	0.00	0.00	48.30	0.00	29.37	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.49	23.93	25.57	18.25	20.21	19.64	20.49	15.76	24.23	12.23	18.23
Enterprise Value to Free Cash Flow (EV/FCFF)	16.98	0.00	66.45	11.44	20.73	0.00	28.08	11.54	36.03	8.58	25.41
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.49	0.19	0.25	0.32	0.28	0.46	0.42	0.51	0.64	1.10	1.74
Long-Term Debt to Equity	0.49	0.19	0.24	0.30	0.28	0.40	0.38	0.48	0.55	0.82	1.50
Financial Leverage	0.42	0.19	0.17	0.23	0.23	0.29	0.36	0.38	0.47	0.70	1.18
Leverage Ratio	1.94	1.52	1.49	1.62	1.69	1.79	1.87	1.92	2.11	2.51	3.41
Compound Leverage Factor	1.67	1.42	1.52	1.68	1.57	22.37	1.68	2.04	3.93	2.71	4.16
Debt to Total Capital	33.02%	15.86%	19.85%	24.41%	21.98%	31.57%	29.54%	33.77%	39.14%	52.35%	63.47%
Short-Term Debt to Total Capital	0.35%	0.22%	0.36%	1.36%	0.03%	4.15%	2.57%	2.05%	5.95%	13.46%	8.53%
Long-Term Debt to Total Capital	32.67%	15.65%	19.49%	23.05%	21.94%	27.43%	26.97%	31.72%	33.19%	38.89%	54.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.12%	0.14%	0.18%	0.03%	0.04%	0.01%	0.02%	0.02%	0.02%	0.03%
Common Equity to Total Capital	66.94%	84.02%	80.01%	75.42%	77.99%	68.39%	70.45%	66.21%	60.85%	47.62%	36.50%
Debt to EBITDA	2.23	2.04	-1.31	-2.81	2.09	6.90	2.20	-2.94	8.51	-4.12	-50.61
Net Debt to EBITDA	1.68	1.53	-1.06	-2.29	1.50	5.57	1.84	-2.39	7.16	-3.60	-43.52
Long-Term Debt to EBITDA	2.20	2.01	-1.29	-2.66	2.08	5.99	2.01	-2.76	7.21	-3.06	-43.80
Debt to NOPAT	4.01	3.44	-1.50	-2.47	5.37	-1,084.29	4.57	-2.96	-35.60	-3.47	-7.88
Net Debt to NOPAT	3.02	2.58	-1.21	-2.01	3.85	-875.71	3.83	-2.41	-29.98	-3.03	-6.78
Long-Term Debt to NOPAT	3.97	3.40	-1.47	-2.33	5.36	-941.90	4.17	-2.78	-30.18	-2.58	-6.82
Altman Z-Score	4.51	3.20	2.57	1.74	3.01	2.07	2.64	1.31	1.71	0.59	0.52
Noncontrolling Interest Sharing Ratio	0.05%	0.12%	0.16%	0.20%	0.14%	0.05%	0.04%	0.02%	0.03%	0.04%	0.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.51	2.27	2.10	1.86	2.01	1.31	1.47	1.62	1.38	1.10	1.51
Quick Ratio	1.44	1.33	1.12	1.00	1.19	0.81	0.86	0.85	0.72	0.52	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	512	-5,621	232	798	623	-651	480	706	254	657	169
Operating Cash Flow to CapEx	694.69%	469.50%	439.66%	287.36%	519.51%	745.98%	462.68%	346.98%	253.02%	256.11%	179.39%
Free Cash Flow to Firm to Interest Expense	9.16	-156.58	6.05	21.56	0.00	0.00	7.86	10.86	3.13	9.52	1.92
Operating Cash Flow to Interest Expense	8.90	15.69	15.72	13.51	0.00	0.00	10.77	7.95	4.65	6.68	2.67
Operating Cash Flow Less CapEx to Interest Expense	7.62	12.35	12.14	8.81	0.00	0.00	8.44	5.66	2.81	4.07	1.18
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.47	0.36	0.42	0.47	0.37	0.46	0.46	0.53	0.58	0.66
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.18	4.07	3.17	3.14	3.20	3.24	3.80	3.14	3.00	3.09	3.05
Fixed Asset Turnover	4.66	5.51	4.77	4.56	4.81	4.19	5.41	5.11	5.08	4.84	4.52
Accounts Payable Turnover	8.69	9.78	7.11	6.75	6.28	5.52	6.68	6.64	6.43	6.72	6.80
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	114.74	89.71	115.29	116.27	114.03	112.56	96.00	116.11	121.50	118.15	119.62
Days Payable Outstanding (DPO)	41.99	37.31	51.31	54.07	58.14	66.15	54.63	55.00	56.72	54.30	53.66
Cash Conversion Cycle (CCC)	72.76	52.40	63.98	62.20	55.89	46.41	41.36	61.10	64.78	63.85	65.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,208	9,274	7,949	6,481	6,125	6,774	6,753	5,391	5,078	3,806	3,342
Invested Capital Turnover	0.81	0.60	0.46	0.55	0.64	0.52	0.63	0.65	0.76	0.85	1.03
Increase / (Decrease) in Invested Capital	-225	6,066	-1,325	-1,468	-356	649	-21	-1,362	-313	-1,272	-464
Enterprise Value (EV)	8,699	13,484	15,390	9,124	12,915	12,749	13,464	8,148	9,134	5,637	4,284
Market Capitalization	7,829	12,324	14,058	7,764	11,883	10,907	11,707	6,568	7,349	3,773	2,281
Book Value per Share	$16.72	$35.15	$28.81	$23.01	$22.90	$22.57	$22.85	$17.73	$15.54	$9.77	$6.71
Tangible Book Value per Share	($1.79)	($3.44)	($3.15)	($3.28)	($2.16)	($7.13)	($5.94)	($3.63)	($4.01)	($4.34)	($3.92)
Total Capital	3,493	9,658	8,270	6,790	6,530	7,212	7,092	5,756	5,412	4,078	3,668
Total Debt	1,153	1,532	1,642	1,657	1,435	2,277	2,095	1,944	2,118	2,135	2,328
Total Long-Term Debt	1,141	1,511	1,612	1,565	1,433	1,978	1,913	1,826	1,796	1,586	2,015
Net Debt	869	1,148	1,321	1,348	1,030	1,839	1,756	1,579	1,784	1,863	2,002
Capital Expenditures (CapEx)	72	120	137	174	123	87	142	149	149	180	131
Debt-free, Cash-free Net Working Capital (DFCFNWC)	448	613	758	658	602	287	434	476	536	434	667
Debt-free Net Working Capital (DFNWC)	733	997	1,078	967	1,007	725	773	841	870	706	993
Net Working Capital (NWC)	721	976	1,048	875	1,005	426	591	723	548	157	680
Net Nonoperating Expense (NNE)	36	14	457	340	11	71	48	294	73	295	303
Net Nonoperating Obligations (NNO)	869	1,148	1,321	1,348	1,030	1,839	1,756	1,579	1,784	1,863	2,002
Total Depreciation and Amortization (D&A)	134	276	319	334	323	334	346	328	343	349	352
Debt-free, Cash-free Net Working Capital to Revenue	16.76%	16.37%	18.97%	16.50%	14.97%	8.60%	10.26%	12.14%	13.52%	11.44%	18.13%
Debt-free Net Working Capital to Revenue	27.40%	26.62%	27.00%	24.26%	25.04%	21.71%	18.27%	21.44%	21.94%	18.61%	26.98%
Net Working Capital to Revenue	26.95%	26.06%	26.24%	21.94%	24.99%	12.76%	13.97%	18.43%	13.82%	4.14%	18.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.79	$1.97	($6.76)	($4.51)	$1.18	($0.38)	$1.93	$0.00	($0.62)	($4.48)	($3.00)
Adjusted Weighted Average Basic Shares Outstanding	140M	218M	229.40M	224.30M	223.10M	219.20M	218.40M	0.00	212M	203.20M	199.40M
Adjusted Diluted Earnings per Share	$1.76	$1.94	($6.76)	($4.51)	$1.17	($0.38)	$1.91	$0.00	($0.62)	($4.48)	($3.00)
Adjusted Weighted Average Diluted Shares Outstanding	142.50M	221.60M	229.40M	224.30M	224.40M	219.20M	220.20M	0.00	212M	203.20M	199.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	140.12M	229.68M	227.38M	223.22M	221.44M	219.05M	217.55M	0.00	207.36M	198.99M	199.75M
Normalized Net Operating Profit after Tax (NOPAT)	337	468	360	244	329	162	471	255	202	132	176
Normalized NOPAT Margin	12.61%	12.49%	9.01%	6.13%	8.17%	4.84%	11.14%	6.50%	5.10%	3.47%	4.79%
Pre Tax Income Margin	12.33%	11.77%	-40.15%	-24.03%	8.40%	-1.50%	12.88%	-26.90%	-4.41%	-24.68%	-13.21%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.86	13.23	-40.93	-24.95	0.00	0.00	9.93	-15.23	-1.16	-12.57	-4.52
NOPAT to Interest Expense	5.14	12.39	-28.55	-18.12	0.00	0.00	7.52	-10.09	-0.73	-8.92	-3.36
EBIT Less CapEx to Interest Expense	5.58	9.88	-44.50	-29.65	0.00	0.00	7.61	-17.52	-3.00	-15.17	-6.01
NOPAT Less CapEx to Interest Expense	3.86	9.05	-32.13	-22.83	0.00	0.00	5.19	-12.38	-2.57	-11.53	-4.85
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.93%	14.97%	-5.05%	-7.81%	31.64%	-120.55%	22.38%	-10.95%	-87.88%	-13.85%	-21.40%
Augmented Payout Ratio	60.81%	203.64%	-30.94%	-32.54%	133.20%	-312.33%	71.05%	-26.74%	-315.15%	-41.32%	-21.40%

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	199,749,333.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	199,749,333.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.05
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	2.95%	-2.56%	-4.28%	0.42%	-10.57%	-7.77%	-4.88%	-4.94%	6.19%	0.11%
EBITDA Growth	87.51%	45.95%	77.63%	-11.04%	-159.44%	-358.64%	5.19%	-129.93%	69.00%	92.36%	-57.04%
EBIT Growth	81.17%	140.63%	712.50%	-25.00%	-99.13%	-758.44%	28.57%	-352.94%	55.00%	75.35%	-128.57%
NOPAT Growth	80.62%	175.66%	1,745.16%	-103.98%	-95.76%	-486.40%	18.12%	-1,423.20%	52.81%	72.69%	-190.06%
Net Income Growth	75.30%	580.00%	173.91%	-104.71%	-86.09%	-694.44%	11.76%	-1,000.00%	13.54%	66.12%	-152.63%
EPS Growth	75.05%	633.33%	200.00%	-105.00%	-96.80%	-753.13%	11.11%	-1,000.00%	13.01%	64.59%	-150.00%
Operating Cash Flow Growth	22.94%	12.68%	219.05%	100.00%	5.22%	-45.63%	-72.00%	-76.92%	-43.97%	16.09%	471.43%
Free Cash Flow Firm Growth	-104.62%	-67.33%	-63.89%	-45.78%	931.41%	125.98%	156.11%	27.67%	135.64%	-59.95%	-50.98%
Invested Capital Growth	-2.45%	-5.81%	-7.69%	-11.35%	-12.69%	-25.05%	-21.95%	-18.02%	-20.43%	-12.19%	-14.75%
Revenue Q/Q Growth	-7.88%	6.86%	-5.83%	3.25%	-3.35%	-4.84%	-2.87%	6.48%	-3.42%	6.31%	-8.43%
EBITDA Q/Q Growth	-192.86%	213.29%	-17.18%	1.48%	-370.80%	-12.94%	133.89%	-128.87%	-180.49%	72.17%	290.63%
EBIT Q/Q Growth	-439.71%	133.33%	-37.18%	4.08%	-1,001.96%	-10.22%	112.43%	-304.76%	-60.47%	39.61%	85.60%
NOPAT Q/Q Growth	-211.75%	155.82%	-75.02%	-125.54%	-5,397.80%	-10.17%	107.64%	-429.36%	-70.31%	36.24%	74.82%
Net Income Q/Q Growth	-412.94%	127.07%	-76.39%	-123.53%	-12,275.00%	13.54%	104.44%	-331.58%	-872.73%	66.12%	93.10%
EPS Q/Q Growth	-412.50%	125.60%	-71.88%	-122.22%	-12,200.00%	15.04%	104.78%	-320.00%	-872.73%	65.42%	93.24%
Operating Cash Flow Q/Q Growth	28.85%	19.40%	-84.38%	732.00%	-32.21%	-38.30%	-91.95%	585.71%	64.58%	27.85%	-60.40%
Free Cash Flow Firm Q/Q Growth	-103.35%	1,160.76%	9.58%	39.43%	-48.70%	188.32%	24.19%	-30.50%	-5.31%	-51.00%	52.03%
Invested Capital Q/Q Growth	-8.30%	0.51%	-0.41%	-3.42%	-9.68%	-13.72%	3.70%	1.44%	-12.34%	-4.79%	0.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.27%	51.58%	53.10%	51.93%	52.05%	49.28%	53.01%	52.35%	48.78%	46.10%	48.52%
EBITDA Margin	-15.10%	16.01%	14.17%	13.92%	-39.01%	-46.30%	16.15%	-4.38%	-12.72%	-3.33%	6.93%
Operating Margin	-24.92%	7.21%	4.41%	5.08%	-48.58%	-56.24%	7.17%	-13.68%	-24.12%	-14.46%	-3.98%
EBIT Margin	-24.39%	7.61%	5.14%	5.18%	-48.37%	-56.02%	7.17%	-13.78%	-22.90%	-13.01%	-2.05%
Profit (Net Income) Margin	-28.09%	7.11%	1.78%	-0.41%	-52.05%	-47.29%	2.16%	-4.70%	-47.35%	-15.09%	-1.14%
Tax Burden Percent	106.40%	126.32%	54.84%	-11.76%	103.56%	81.84%	43.18%	28.76%	186.09%	98.64%	23.81%
Interest Burden Percent	108.23%	74.03%	63.27%	66.67%	103.91%	103.16%	69.84%	118.60%	111.11%	117.60%	233.33%
Effective Tax Rate	0.00%	-26.32%	45.16%	111.76%	0.00%	0.00%	56.82%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-13.42%	6.90%	1.81%	-0.45%	-28.03%	-33.62%	2.56%	-7.91%	-15.45%	-10.43%	-2.80%
ROIC Less NNEP Spread (ROIC-NNEP)	-19.63%	5.70%	1.48%	-0.34%	-37.56%	-37.55%	2.12%	-5.55%	-29.38%	-12.89%	-2.08%
Return on Net Nonoperating Assets (RNNOA)	-9.12%	2.70%	0.78%	-0.18%	-23.08%	-26.15%	1.50%	-4.26%	-29.27%	-15.18%	-2.48%
Return on Equity (ROE)	-22.55%	9.60%	2.59%	-0.63%	-51.11%	-59.77%	4.06%	-12.17%	-44.72%	-25.60%	-5.29%
Cash Return on Invested Capital (CROIC)	1.21%	4.84%	7.45%	11.07%	9.15%	14.78%	11.32%	3.48%	8.75%	4.72%	5.96%
Operating Return on Assets (OROA)	-13.04%	4.02%	2.74%	2.78%	-27.29%	-32.38%	4.05%	-7.80%	-13.52%	-8.56%	-1.34%
Return on Assets (ROA)	-15.02%	3.76%	0.95%	-0.22%	-29.36%	-27.34%	1.22%	-2.66%	-27.95%	-9.93%	-0.74%
Return on Common Equity (ROCE)	-22.56%	9.60%	2.59%	-0.63%	-51.16%	-59.74%	4.06%	-12.17%	-44.73%	-25.59%	-5.28%
Return on Equity Simple (ROE_SIMPLE)	-6.49%	0.00%	-2.82%	-5.91%	-16.46%	0.00%	-45.17%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-165	92	23	-5.88	-323	-356	27	-90	-153	-97	-25
NOPAT Margin	-17.44%	9.11%	2.42%	-0.60%	-34.01%	-39.37%	3.09%	-9.57%	-16.88%	-10.12%	-2.78%
Net Nonoperating Expense Percent (NNEP)	6.21%	1.20%	0.33%	-0.10%	9.53%	3.93%	0.44%	-2.36%	13.93%	2.47%	-0.73%
Return On Investment Capital (ROIC_SIMPLE)	-	1.70%	-	-	-	-8.74%	0.63%	-2.05%	-3.94%	-2.65%	-0.69%
Cost of Revenue to Revenue	47.73%	48.42%	46.90%	48.07%	47.95%	50.72%	46.99%	47.65%	51.22%	53.90%	51.48%
SG&A Expenses to Revenue	39.28%	40.42%	43.55%	40.55%	41.01%	44.31%	40.73%	36.54%	39.27%	39.85%	39.89%
R&D to Revenue	4.86%	4.25%	4.41%	4.17%	4.21%	4.64%	4.10%	3.95%	4.09%	4.16%	5.00%
Operating Expenses to Revenue	77.19%	44.37%	48.69%	46.85%	100.63%	105.52%	45.85%	66.03%	72.90%	60.56%	52.50%
Earnings before Interest and Taxes (EBIT)	-231	77	49	51	-460	-507	63	-129	-207	-125	-18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-143	162	135	137	-371	-419	142	-41	-115	-32	61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.10	2.23	2.10	1.69	2.20	1.94	1.48	1.61	1.71	1.70	1.76
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.80	1.85	1.74	1.33	1.41	0.99	0.80	0.86	0.70	0.62	0.63
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	1.63%	1.61%	1.76%	2.41%	2.29%	3.37%	4.28%	4.03%	5.04%	5.60%	5.52%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.73	1.80	1.71	1.43	1.68	1.48	1.24	1.30	1.30	1.28	1.30
Enterprise Value to Revenue (EV/Rev)	2.22	2.30	2.19	1.79	1.90	1.49	1.32	1.42	1.26	1.16	1.19
Enterprise Value to EBITDA (EV/EBITDA)	44.23	36.68	28.05	24.03	117.55	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	24.39	24.23	20.42	13.27	13.87	12.23	11.08	18.41	20.65	18.23	16.28
Enterprise Value to Free Cash Flow (EV/FCFF)	141.47	36.03	22.02	12.15	17.10	8.58	9.64	33.65	13.17	25.41	20.02
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.59	0.64	0.64	0.69	0.89	1.10	1.16	1.22	1.62	1.74	1.70
Long-Term Debt to Equity	0.53	0.55	0.54	0.57	0.72	0.82	0.79	1.13	1.36	1.50	1.52
Financial Leverage	0.46	0.47	0.53	0.54	0.61	0.70	0.71	0.77	1.00	1.18	1.20
Leverage Ratio	2.11	2.11	2.15	2.15	2.36	2.51	2.50	2.58	3.09	3.41	3.39
Compound Leverage Factor	2.28	1.56	1.36	1.43	2.45	2.58	1.75	3.06	3.44	4.01	7.91
Debt to Total Capital	37.12%	39.14%	39.08%	40.65%	47.10%	52.35%	53.74%	55.05%	61.84%	63.47%	62.90%
Short-Term Debt to Total Capital	3.49%	5.95%	6.41%	7.01%	8.97%	13.46%	17.08%	4.22%	9.76%	8.53%	6.47%
Long-Term Debt to Total Capital	33.63%	33.19%	32.67%	33.64%	38.13%	38.89%	36.66%	50.84%	52.08%	54.93%	56.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.07%	0.02%	0.00%	0.00%	-0.02%	0.02%	0.00%	0.02%	0.00%	0.03%	0.03%
Common Equity to Total Capital	62.95%	60.85%	60.92%	59.35%	52.92%	47.62%	46.26%	44.92%	38.16%	36.50%	37.07%
Debt to EBITDA	10.05	8.51	6.79	7.21	35.19	-4.12	-4.57	-3.49	-5.53	-50.61	-17.61
Net Debt to EBITDA	8.49	7.16	5.84	6.25	30.49	-3.60	-3.79	-2.97	-4.69	-43.52	-16.11
Long-Term Debt to EBITDA	9.11	7.21	5.67	5.97	28.49	-3.06	-3.12	-3.22	-4.66	-43.80	-15.80
Debt to NOPAT	-30.57	-35.60	-72.82	-42.23	-10.66	-3.47	-3.89	-3.31	-4.32	-7.88	-6.14
Net Debt to NOPAT	-25.82	-29.98	-62.68	-36.62	-9.24	-3.03	-3.23	-2.82	-3.67	-6.78	-5.62
Long-Term Debt to NOPAT	-27.70	-30.18	-60.87	-34.95	-8.63	-2.58	-2.65	-3.06	-3.64	-6.82	-5.51
Altman Z-Score	1.70	1.78	1.77	1.51	1.14	0.79	0.93	0.94	0.68	0.68	0.77
Noncontrolling Interest Sharing Ratio	-0.04%	0.03%	-0.04%	-0.06%	-0.09%	0.04%	0.00%	0.02%	-0.03%	0.06%	0.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.57	1.38	1.43	1.33	1.25	1.10	1.10	1.69	1.47	1.51	1.53
Quick Ratio	0.79	0.72	0.71	0.66	0.63	0.52	0.56	0.86	0.72	0.76	0.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	405	444	619	318	916	1,137	790	748	367	558
Operating Cash Flow to CapEx	362.16%	400.00%	73.53%	400.00%	327.91%	170.59%	38.89%	150.00%	202.56%	246.34%	76.92%
Free Cash Flow to Firm to Interest Expense	-2.01	20.26	24.67	36.42	17.64	57.23	59.85	32.93	32.54	16.67	23.23
Operating Cash Flow to Interest Expense	7.05	8.00	1.39	12.24	7.83	5.44	0.37	2.00	3.43	4.59	1.67
Operating Cash Flow Less CapEx to Interest Expense	5.11	6.00	-0.50	9.18	5.44	2.25	-0.58	0.67	1.74	2.73	-0.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.53	0.53	0.54	0.56	0.58	0.56	0.57	0.59	0.66	0.65
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	2.98	3.00	2.94	2.94	2.94	3.09	2.94	2.77	2.73	3.05	2.96
Fixed Asset Turnover	5.37	5.08	5.08	4.99	4.97	4.84	4.73	4.51	4.37	4.52	4.46
Accounts Payable Turnover	6.96	6.43	6.84	6.75	6.68	6.72	6.49	6.39	6.30	6.80	7.03
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	122.29	121.50	124.34	123.99	124.21	118.15	124.13	131.99	133.72	119.62	123.38
Days Payable Outstanding (DPO)	52.44	56.72	53.37	54.10	54.67	54.30	56.24	57.10	57.90	53.66	51.93
Cash Conversion Cycle (CCC)	69.85	64.78	70.97	69.88	69.54	63.85	67.89	74.89	75.83	65.96	71.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,052	5,078	5,057	4,884	4,411	3,806	3,947	4,004	3,510	3,342	3,365
Invested Capital Turnover	0.77	0.76	0.75	0.75	0.82	0.85	0.83	0.83	0.92	1.03	1.01
Increase / (Decrease) in Invested Capital	-127	-313	-421	-625	-641	-1,272	-1,110	-880	-901	-464	-582
Enterprise Value (EV)	8,757	9,134	8,638	6,992	7,405	5,637	4,910	5,209	4,563	4,284	4,364
Market Capitalization	7,080	7,349	6,839	5,172	5,485	3,773	2,973	3,165	2,531	2,281	2,317
Book Value per Share	$15.94	$15.54	$15.71	$14.76	$12.29	$9.77	$10.10	$9.83	$7.41	$6.71	$6.60
Tangible Book Value per Share	($3.35)	($4.01)	($3.67)	($4.26)	($4.85)	($4.34)	($4.19)	($3.52)	($4.30)	($3.92)	($3.74)
Total Capital	5,361	5,412	5,348	5,163	4,707	4,078	4,345	4,363	3,873	3,668	3,555
Total Debt	1,990	2,118	2,090	2,099	2,217	2,135	2,335	2,402	2,395	2,328	2,236
Total Long-Term Debt	1,803	1,796	1,747	1,737	1,795	1,586	1,593	2,218	2,017	2,015	2,006
Net Debt	1,681	1,784	1,799	1,820	1,921	1,863	1,937	2,043	2,032	2,002	2,046
Capital Expenditures (CapEx)	37	40	34	52	43	51	18	32	39	41	52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	573	536	624	518	505	434	529	625	682	667	678
Debt-free Net Working Capital (DFNWC)	882	870	915	797	801	706	927	984	1,045	993	868
Net Working Capital (NWC)	695	548	572	435	379	157	185	800	667	680	638
Net Nonoperating Expense (NNE)	101	20	6.03	-1.88	172	72	8.20	-46	275	48	-15
Net Nonoperating Obligations (NNO)	1,681	1,784	1,799	1,820	1,921	1,863	1,937	2,043	2,032	2,002	2,046
Total Depreciation and Amortization (D&A)	88	85	86	86	89	88	79	88	92	93	79
Debt-free, Cash-free Net Working Capital to Revenue	14.56%	13.52%	15.84%	13.30%	12.95%	11.44%	14.22%	17.03%	18.82%	18.13%	18.42%
Debt-free Net Working Capital to Revenue	22.41%	21.94%	23.22%	20.46%	20.54%	18.61%	24.93%	26.80%	28.84%	26.98%	23.58%
Net Working Capital to Revenue	17.66%	13.82%	14.52%	11.17%	9.72%	4.14%	4.97%	21.79%	18.41%	18.48%	17.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.25)	$0.31	$0.09	($0.02)	($2.46)	($2.09)	$0.10	($0.22)	($2.14)	($0.74)	($0.05)
Adjusted Weighted Average Basic Shares Outstanding	211.80M	212M	207.40M	205.60M	201M	203.20M	199.10M	199.30M	199.50M	199.40M	199.90M
Adjusted Diluted Earnings per Share	($1.25)	$0.32	$0.09	($0.02)	($2.46)	($2.09)	$0.10	($0.22)	($2.14)	($0.74)	($0.05)
Adjusted Weighted Average Diluted Shares Outstanding	211.80M	212M	208.50M	205.60M	201M	203.20M	199.80M	199.30M	199.50M	199.40M	199.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	211.86M	207.36M	207.63M	202.71M	198.78M	198.99M	199.29M	199.48M	199.55M	199.75M	200.33M
Normalized Net Operating Profit after Tax (NOPAT)	54	49	27	50	46	2.10	50	78	34	14	22
Normalized NOPAT Margin	5.69%	4.84%	2.82%	5.05%	4.78%	0.23%	5.73%	8.30%	3.79%	1.46%	2.55%
Pre Tax Income Margin	-26.40%	5.63%	3.25%	3.46%	-50.26%	-57.79%	5.01%	-16.35%	-25.44%	-15.30%	-4.77%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-12.16	3.85	2.72	3.00	-25.56	-31.69	3.32	-5.38	-9.00	-5.68	-0.75
NOPAT to Interest Expense	-8.69	4.61	1.28	-0.35	-17.97	-22.27	1.43	-3.73	-6.63	-4.42	-1.02
EBIT Less CapEx to Interest Expense	-14.11	1.85	0.83	-0.06	-27.94	-34.88	2.37	-6.71	-10.70	-7.55	-2.92
NOPAT Less CapEx to Interest Expense	-10.64	2.61	-0.61	-3.40	-20.36	-25.46	0.48	-5.07	-8.33	-6.29	-3.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-51.14%	-87.88%	-128.26%	-66.85%	-30.49%	-13.85%	-14.21%	-13.50%	-14.42%	-21.40%	-20.41%
Augmented Payout Ratio	-119.63%	-315.15%	-291.30%	-232.60%	-128.05%	-41.32%	-14.21%	-24.05%	-14.42%	-21.40%	-20.41%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, year-over-year read on DENTSPLY SIRONA Inc. (XRAY) using quarterly statements from 2022 through 2025. The points focus on revenue, profitability, cash flow, and balance-sheet trends across the four most recent fiscal years.

Q4 2025 gross margin improved to about 46% (443M gross profit on 961M revenue) versus roughly 44% in Q4 2024 (446M gross profit on 1,012M revenue), despite a lower revenue base.
Q1 2025 shows quarterly profitability with net income of about 19M and basic/diluted earnings per share of around 0.10, indicating a positive margin swing in that quarter.
Operating cash flow remained positive in several 2025 quarters, with net cash from continuing operating activities of about 79M in Q3 2025 and about 101M in Q4 2025, signaling ongoing cash generation from core operations.
Revenue and margins have varied quarter to quarter across 2022–2025, with 2025 quarters running roughly in the 0.88B–1.01B revenue band (Q3: ~0.90B; Q4: ~0.96B; Q2: ~0.94B; Q1: ~0.88B), reflecting cyclicality and mix shifts.
Impairment charges in 2025 are material (262M in Q3 and 153M in Q4) and weigh on operating income, though these are non-cash and do not directly impact near-term cash flow.
Long-term debt rose through 2025, with LT debt around 2.02B in Q3 2025 versus about 1.59B in Q3 2024, indicating a higher leverage level over the period.
Net income has been negative in most quarters, including -145M in Q4 2025 and -428M in Q3 2025, underscoring ongoing profitability challenges despite occasional quarterly upticks.
Net cash from financing activities was negative in several 2025 quarters (e.g., around -99M in Q4 2025 and -36M in Q3 2025), indicating cash outflows related to debt management and distributions.
Balance-sheet leverage remains elevated, with total liabilities well above equity (total liabilities near 4.17B and total equity around 1.48B in 2025 Q3), suggesting meaningful leverage and ongoing interest/servicing costs.

05/15/26 11:36 PM ETAI Generated. May Contain Errors.

DENTSPLY SIRONA Financials - Frequently Asked Questions

According to the most recent income statement we have on file, DENTSPLY SIRONA's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

DENTSPLY SIRONA's net income appears to be on an upward trend, with a most recent value of -$598 million in 2025, falling from $251.10 million in 2015. The previous period was -$910 million in 2024. See where experts think DENTSPLY SIRONA is headed by visiting DENTSPLY SIRONA's forecast page.

DENTSPLY SIRONA's total operating income in 2025 was -$422 million, based on the following breakdown:

Total Gross Profit: $1.84 billion
Total Operating Expenses: $2.26 billion

Over the last 10 years, DENTSPLY SIRONA's total revenue changed from $2.67 billion in 2015 to $3.68 billion in 2025, a change of 37.6%.

DENTSPLY SIRONA's total liabilities were at $4.09 billion at the end of 2025, a 7.3% increase from 2024, and a 98.2% increase since 2015.

In the past 10 years, DENTSPLY SIRONA's cash and equivalents has ranged from $272 million in 2024 to $438 million in 2020, and is currently $326 million as of their latest financial filing in 2025.

Over the last 10 years, DENTSPLY SIRONA's book value per share changed from 16.72 in 2015 to 6.71 in 2025, a change of -59.9%.

Related Companies

Financial statements for NASDAQ:XRAY last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Financials

Financials Breakdown Chart

Key Financial Trends

DENTSPLY SIRONA Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Financials

Annual Income Statements for DENTSPLY SIRONA

Quarterly Income Statements for DENTSPLY SIRONA

Annual Cash Flow Statements for DENTSPLY SIRONA

Quarterly Cash Flow Statements for DENTSPLY SIRONA

Annual Balance Sheets for DENTSPLY SIRONA

Quarterly Balance Sheets for DENTSPLY SIRONA

Annual Metrics And Ratios for DENTSPLY SIRONA

Quarterly Metrics And Ratios for DENTSPLY SIRONA

Financials Breakdown Chart

Key Financial Trends

DENTSPLY SIRONA Financials - Frequently Asked Questions

When does DENTSPLY SIRONA's financial year end?

How has DENTSPLY SIRONA's net income changed over the last 10 years?

What is DENTSPLY SIRONA's operating income?

How has DENTSPLY SIRONA's revenue changed over the last 10 years?

How much debt does DENTSPLY SIRONA have?

How much cash does DENTSPLY SIRONA have?

How has DENTSPLY SIRONA's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools